V. Krishna
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Natural Antidiabetic Agents Studies 9
- Co-authors
- B.G. Harish (3 shared papers)K. L. Mankani (4 shared papers)H. Raja Naika (5 shared papers)R. Sharath (2 shared papers)K. M. Mahadevan (1 shared paper)B. A. Rahiman (1 shared paper)B. K. Manjunatha (3 shared papers)Mohamed B. Khadeer Ahamed (1 shared paper)
- Journals
- World Journal of Microbiology and Biotechnology (1 paper)Phytomedicine (1 paper)European Journal of Medicinal Chemistry (1 paper)Archives of Pharmacal Research (1 paper)Phytotherapy Research (1 paper)
- Partner nations
- India
In The Last Decade
V. Krishna
27 papers receiving 521 citations
Peers
Comparison fields: 5 of 79
- Toxicology 95
- Complementary and alternative medicine 140
- Drug Discovery 3
- Pharmacology 103
- Rehabilitation 66
Countries citing papers authored by V. Krishna
This map shows the geographic impact of V. Krishna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Krishna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Krishna more than expected).
Fields of papers citing papers by V. Krishna
This network shows the impact of papers produced by V. Krishna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Krishna. The network helps show where V. Krishna may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Krishna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 165 | |
| 2 | 2008 | 98 | |
| 3 | 2005 | 59 | |
| 4 | Evaluation of hepatoprotective activity of Clerodendrum serratum L. | 2007 | 41 |
| 5 | 2010 | 34 | |
| 6 | 2006 | 19 | |
| 7 | 2012 | 19 | |
| 8 | 2014 | 19 | |
| 9 | Hypolipidemic activity of gum ghatti of Anogeissus latifolia. | 2009 | 18 |
| 10 | 2011 | 16 | |
| 11 | 2012 | 15 | |
| 12 | 2020 | 12 | |
| 13 | 2011 | 11 | |
| 14 | 2006 | 10 | |
| 15 | 2016 | 10 | |
| 16 | 2012 | 10 | |
| 17 | Antibacterial Activity of Bacoside-A- an Active Constituent Isolated of Bacopa Monnieri (L.) Wettest . | 2008 | 10 |
| 18 | Antimicrobial Activity of Extracts from the Leaves of Clematis gouriana Roxb. | 2007 | 8 |
| 19 | 2012 | 6 | |
| 20 | IN-SILICO DRUG DESIGNING USING B-SITOSTEROL ISOLATED FROM FLAVERIA TRINERVIA AGAINST PEPTIDE DEFORMYLASE PROTEIN TO HYPOTHESIZE BACTERICIDAL EFFECT | 2012 | 6 |
About V. Krishna
V. Krishna is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Plant Science, Pharmacology and Complementary and alternative medicine, having authored 28 papers that have together received 604 indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (9 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Ethnobotanical and Medicinal Plants Studies (4 papers), Phytochemicals and Antioxidant Activities (3 papers), Medicinal Plants and Neuroprotection (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Essential Oils and Antimicrobial Activity (3 papers) and Antimicrobial Peptides and Activities (2 papers). The work is most often cited by research in Toxicology (95 citations), Complementary and alternative medicine (140 citations), Drug Discovery (3 citations), Pharmacology (103 citations) and Rehabilitation (66 citations). V. Krishna has collaborated with scholars based in India. Frequent co-authors include B.G. Harish, K. L. Mankani, H. Raja Naika, R. Sharath, K. M. Mahadevan, B. A. Rahiman, B. K. Manjunatha, Mohamed B. Khadeer Ahamed, S. M. Vidya and K. Lingaraju. Their work appears in journals such as World Journal of Microbiology and Biotechnology, Phytomedicine, European Journal of Medicinal Chemistry, Archives of Pharmacal Research and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.